PAREXEL Experts to Offer Insights Into Outsourcing Best Practices at 17th Annual...

PAREXEL Experts to Offer Insights Into Outsourcing Best Practices at 17th
Annual Partnerships with CROs Conference

BOSTON, April 10 /PRNewswire-FirstCall/ -- Senior experts from PAREXEL
International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical
services provider, will discuss best practices for successful partnerships at
the 17th Annual Partnerships with CROs conference, to be held April 14-16,
2008 in Las Vegas, Nevada. PAREXEL is an Associate Sponsor of the conference.
PAREXEL experts will present in the following sessions, which address the
implementation of metrics to enhance partnership performance, and strategies
to successfully leverage emerging markets for global clinical trials:
Monday, April 14
Implementing Performance Metrics to Drive Time, Cost and Quality, and
Enhance Partnership Performance (workshop)
Kate Trainor, Vice President of Integration Services, Perceptive
Informatics, PAREXEL
(9:30 a.m. MT)

Tuesday, April 15
Outsourcing Clinical Trials in Emerging Regions: China
Karen Chu, Executive Director of International Clinical Operations,
PAREXEL APEX
(2:00 p.m. MT)

For more than 25 years, clients worldwide have relied on PAREXEL to
provide integrated clinical development, regulatory affairs consulting, and
commercialization services, as well as technologies that expedite
time-to-market. Attendees at the 17th Annual Partnerships with CROs
conference can visit with PAREXEL's Booth #123 in the exhibit hall to discuss
these capabilities.
Visitors to PAREXEL's booth will receive a copy of the article "Create a
Successful Project Plan for Global Clinical Trials," recently published in
Applied Clinical Trials, by Diego Glancszpigel, Vice President of Clinical
Operations for Latin America and Graciela Racaro, Senior Director of Clinical
Operations for Latin America at PAREXEL.
For more information about PAREXEL visit http://www.PAREXEL.com or Booth
#123 at the 17th Annual Partnerships with CROs conference.
About PAREXEL International
PAREXEL International Corporation is a leading global bio/pharmaceutical
services organization, providing a broad range of knowledge-based contract
research, medical communications and consulting services to the worldwide
pharmaceutical, biotechnology and medical device industries. Committed to
providing solutions that expedite time-to-market and peak-market penetration,
PAREXEL has developed significant expertise across the development and
commercialization continuum, from drug development and regulatory consulting
to clinical pharmacology, clinical trials management, medical education and
reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL,
provides advanced technology solutions, including medical imaging, to
facilitate the clinical development process. Headquartered near Boston,
Massachusetts, PAREXEL operates in 64 locations throughout 51 countries around
the world, and has more than 7,300 employees. For more information about
PAREXEL International visit http://www.PAREXEL.com.
This release contains "forward-looking" statements regarding future
results and events. For this purpose, any statements contained herein that
are not statements of historical fact may be deemed forward-looking
statements. Without limiting the foregoing, the words "believes,"
"anticipates," "plans," "expects," "intends," "appears," "estimates,"
"projects," "targets," and similar expressions are also intended to identify
forward-looking statements. The forward-looking statements in this release
involve a number of risks and uncertainties. The Company's actual future
results may differ significantly from the results discussed in the
forward-looking statements contained in this release. Important factors that
might cause such a difference include, but are not limited to, risks
associated with: actual operating performance; actual expense savings and
other operating improvements resulting from recent restructurings; the loss,
modification, or delay of contracts which would, among other things, adversely
impact the Company's recognition of revenue included in backlog; the Company's
dependence on certain industries and clients; the Company's ability to win new
business, manage growth and costs, and attract and retain employees; the
Company's ability to complete additional acquisitions and to integrate newly
acquired businesses or enter into new lines of business; the impact on the
Company's business of government regulation of the drug, medical device and
biotechnology industry; consolidation within the pharmaceutical industry and
competition within the biopharmaceutical services industry; the potential for
significant liability to clients and third parties; the potential adverse
impact of health care reform; and the effects of exchange rate fluctuations
and other international economic, political, and other risks. Such factors
and others are discussed more fully in the section entitled "Risk Factors" of
the Company's Quarterly Report on Form 10-Q for the period ended December 31,
2007 as filed with the SEC on February 7, 2008, which "Risk Factors"
discussion is incorporated by reference in this press release. The
forward-looking statements included in this press release represent the
Company's estimates as of the date of this release. The Company specifically
disclaims any obligation to update these forward-looking statements in the
future. These forward-looking statements should not be relied upon as
representing the Company's estimates or views as of any date subsequent to the
date of this press release.
PAREXEL is a registered trademark of PAREXEL International Corporation,
and PERCEPTIVE INFORMATICS is a registered trademark of Perceptive
Informatics, Inc. All other names or marks may be registered trademarks or
trademarks of their respective business and are hereby acknowledged.
Contacts:
Jennifer Baird, Senior Director of Public Relations
PAREXEL International
Tel: +781-434-4409
Email: Jennifer.Baird@PAREXEL.com

Rebecca Passo
SHIFT Communications
Tel: +617-681-1817
Email: rpasso@shiftcomm.com

SOURCE PAREXEL International Corporation

Jennifer Baird, Senior Director of Public Relations of PAREXEL International,
+1-781-434-4409, Jennifer.Baird@PAREXEL.com; or Rebecca Passo of SHIFT
Communications for PAREXEL, +1-617-681-1817, rpasso@shiftcomm.com